Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial
曲妥珠单抗-帕妥珠单抗联合艾立布林或紫杉烷类药物作为人表皮生长因子2阳性局部晚期/转移性乳腺癌的一线化疗方案:随机非劣效性III期EMERALD试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-01888
Yamashita, Toshinari; Saji, Shigehira; Takano, Toshimi; Naito, Yoichi; Tsuneizumi, Michiko; Yoshimura, Akiyo; Takahashi, Masato; Tsurutani, Junji; Iwatani, Tsuguo; Kitada, Masahiro; Tada, Hiroshi; Mori, Natsuko; Higuchi, Toru; Iwasa, Tsutomu; Araki, Kazuhiro; Koizumi, Kei; Hasegawa, Hiroki; Uchida, Yohei; Morita, Satoshi; Masuda, Norikazu